Results 701-720 of 3,336 for speaker:Kate O'Connell

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: Okay, I missed that.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: I will have to get through it at some point. Does the witness have any answers as to why the data we received was unrelated to the time of the audit? Why was that decided? Who decided on that? I need a quick answer; I do not want to waste time.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: It seems strange. Dr. McKenna spoke earlier about the rate of false negatives in testing ranging between 10% and 40% in the international literature. Deputy Catherine Murphy asked earlier if there were any other issues that might explain why such discrepancies exist. When the witnesses were getting the audit data back from external labs was it delivered in one tranche or was it broken down...

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: The trigger is a cancer diagnosis, and then a review is initiated. Did the witness ever produce a spreadsheet naming the case and attaching it to the relevant laboratory? When the review was carried out, and person A's slide was taken out from laboratory X, was a chart ever produced with the concerning result versus laboratory?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: Did the witness find out anything?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: Is it the case that one laboratory can be at 90% and another at 50%, and the average then would be 70%?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: The witness was not trying.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: The witness was aware of the actual false negatives on a per-lab basis.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: We heard from the witnesses yesterday about the types of false negatives. Was the witness looking just at false negatives or at the types of false negatives? I understand that this is a screening process, but in the case of Vicky Phelan the retrospective slide had very clear evidence of cancer. Did the witness quantify the type of false negative, or the degree of the miss?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: That is irrelevant to my point.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: If a set of eyes is looking at two smears there might be a false negative because of an interpretation error. However, the discrepancy on Vicky Phelan's false negative smear was almost impossible to miss. Was that degree of miss looked at?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: Does the witness have anything to show us in that regard?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: We heard evidence yesterday that in 2008 we had the highest rate of cervical cancer. Our slides were sent to another population group - the United States - where the parameters for testing are totally different and where those with private health insurance get smears. Was this looked at before this project began? Was epidemiological or population data looked at? It may be the case that...

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: Does the witness believe there is no problem with that? If the populations are totally different might that lead to operator error? The baseline is different in different countries.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: If a person is looking at two sets of slides, one from Ireland, done every three years, and one from the States, done every year, is there a greater possibility of operator error?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: I am talking about the slide that a person was looking at a second or a minute before. In the process of a person looking at slides-----

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: When a person was diagnosed with cancer, triggering an audit, who audited the slides? Was it the same lab? Was it a slide on a shelf or was it photographs of a microscopic image of a slide? Was it looked at by the same company? Was the review of the slide done by the same company that originally read the slide?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: Its team.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: They were policing or auditing themselves.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed)
2016 Financial Statements of the State Claims Agency (Resumed)
2016 Financial Statements of the HSE (Resumed) (17 May 2018)

Kate O'Connell: Earlier, Dr. O'Keeffe said that she had seen slides in response to the audit findings. Does she recall this? It was when someone asked who had invited her -----